NCT05450367View on ClinicalTrials.gov

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.

CompletedOBSERVATIONAL
Enrollment

249

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

July 15, 2022

Study Completion Date

July 15, 2022

Conditions
Blood Cancer
Interventions
OTHER

Data collection

Data collection

Trial Locations (1)

75014

Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospital, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05450367 - Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy. | Biotech Hunter | Biotech Hunter